Concepedia

Jean-Claude Vedovato

JV

Statistics

Publications

11

Citations

417

H-Index

11

Active since

2003

Affiliations

Pierre Fabre (France)(Current)

National Cancer Center Hospital East

Vall d'Hebron Hospital Universitari

Memorial Sloan Kettering Cancer Center

Casa Sollievo della Sofferenza

Jean-Claude Vedovato is an author at Pierre Fabre (France) specializing in oncology, radiation oncology, and medicine.

Top concepts

Publications per year

2003–2023

11

Publications

11

Cetuximab+FOLFIRI as first-line treatment for metastatic colorectal CA

P. Rougier, Jean‐Luc Raoul, Jean‐Luc Van Laethem et al. · Journal of Clinical Oncology · 2004 · 88 citations

, , +15

ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated <i>BRAF</i><sup>V600E</sup>-Mutant Metastatic Colorectal Cancer

Eric Van Cutsem, Rona Yaeger, Takayuki Yoshino et al. · Journal of Clinical Oncology · 2023 · 86 citations · Full text

Pharmacokinetic profile of cetuximab (Erbitux™) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma

Catherine Delbaldo, Jean‐Yves Pierga, Véronique Dièras et al. · European Journal of Cancer · 2005 · 80 citations

, , +7

LBA-5 ANCHOR CRC: a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E-mutant metastatic colorectal cancer

Axel Grothey, Josep Tabernero, Rona Yaeger et al. · Annals of Oncology · 2020 · 37 citations · Full text

, , +7

Cetuximab+FOLFIRI as first-line treatment for metastatic colorectal CA

P. Rougier, Jean‐Luc Raoul, Jean‐Luc Van Laethem et al. · Journal of Clinical Oncology · 2004 · 28 citations

, , +15

1–5 of 11